Influenza vaccines. A reappraisal of their use

Drugs
A M Palache

Abstract

The medical and economic burden associated with annual influenza activity is well known and well documented. Yearly updated influenza vaccines are available to combat the disease and its consequences. In many countries, less than half of the high risk patients are being vaccinated, despite recommendations to do so by national health authorities. Scientific evidence on the safety, tolerance, efficacy and effectiveness of currently existing inactivated influenza vaccines unambiguously demonstrates the favourable benefit/risk ratio of influenza immunisations for high risk patients and strongly suggests an economic benefit of influenza immunisation programmes. Because of both the successful world-wide efforts of the WHO to optimise the chance of an adequate antigenic match between vaccine and epidemic strains each year and the available scientific data about the inactivated influenza vaccines, influenza immunisations should be offered annually to high risk patients. On the basis of the available evidence, offering a vaccination to such patients should be considered an ethical obligation.

Citations

Jul 26, 2003·American Journal of Preventive Medicine·Gregory A PolandUNKNOWN National Vaccine Advisory Committee, Ad Hoc Working Group for the Development of Standards for Adult Immunization Practices
Jun 29, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T G Boyce, G A Poland
Apr 12, 2002·The Lancet Infectious Diseases·Cassandra D SalgadoFrederick G Hayden
Jan 27, 2005·Viral Immunology·Lidia B BrydakMachaka Magdalena
Aug 3, 2010·AAPS PharmSciTech·Yeu-Chun KimMark R Prausnitz
Nov 8, 2002·Drugs·Eelko HakTheo J M Verheij
Nov 10, 2005·PharmacoEconomics·Larry D LyndBernie J O'Brien
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Alison P GalvaniGretchen B Chapman
Jul 24, 2002·Sozial- Und Präventivmedizin·David WilsonSandra Klason
Feb 3, 2006·Expert Review of Vaccines·Nicola A HananiaMario Castro
Feb 16, 2005·Expert Opinion on Biological Therapy·Mohammad MadjidWard Casscells
Mar 1, 2006·Expert Opinion on Biological Therapy·G W Rose, C L Cooper
Jun 16, 2001·Chest·E C OliveiraG Colice
Jun 30, 2009·Vaccine·Arnold S MontoIain Stephenson
Dec 17, 2009·Pediatric Annals·Christy M Tabarani, Joseph B Domachowske
Aug 14, 2009·Journal of Travel Medicine·Jürgen RingwaldReinhold Eckstein
Jun 5, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Petar MamulaRobert N Baldassano
Nov 18, 2006·Pharmacoepidemiology and Drug Safety·Peter MacCallumDeborah Ashby
Oct 13, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Peter J MazzoneJanet R Mauer
May 28, 2004·Virus Research·Claude HannounJames Piercy
Apr 22, 2004·The Journal of Allergy and Clinical Immunology·Nicola A HananiaUNKNOWN American Lung Association Asthma Clinical Research Centers
Apr 13, 2000·Pediatric Clinics of North America·A Malhotra, L R Krilov
Nov 24, 2004·Infectious Disease Clinics of North America·Cynthia G Whitney, Scott A Harper
Nov 30, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Michael F ParryDiane Baranowsky
Jan 10, 2002·Revista Do Instituto De Medicina Tropical De São Paulo·T M de PaivaS Takimoto
Jun 11, 2004·Journal of Intensive Care Medicine·Eduardo C OliveiraGene L Colice
Apr 11, 2003·Scandinavian Journal of Infectious Diseases·Ingrid UhnooUNKNOWN Swedish Consensus Group
Jun 14, 2003·Revista Da Sociedade Brasileira De Medicina Tropical·Eduardo Forleo-NetoJoão Toniolo-Neto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.